Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors

NCT00639262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastases
Primary Brain Tumors

Interventions

DRUG: Sorafenib
DRUG: Temozolomide
RADIATION: Radiotherapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]